The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
The global Rofecoxib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rofecoxib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rofecoxib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rofecoxib include Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer and Tremeau, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rofecoxib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rofecoxib.
Report Scope
The Rofecoxib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rofecoxib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rofecoxib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Segment by Type
Oral Suspension.
Tablet-Form
Segment by Application
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rofecoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rofecoxib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
The global Rofecoxib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Rofecoxib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Rofecoxib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Rofecoxib include Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer and Tremeau, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rofecoxib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rofecoxib.
Report Scope
The Rofecoxib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rofecoxib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rofecoxib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Segment by Type
Oral Suspension.
Tablet-Form
Segment by Application
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rofecoxib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rofecoxib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Rofecoxib Market Overview
1.1 Product Overview and Scope of Rofecoxib
1.2 Rofecoxib Segment by Type
1.2.1 Global Rofecoxib Market Value Comparison by Type (2024-2030)
1.2.2 Oral Suspension.
1.2.3 Tablet-Form
1.3 Rofecoxib Segment by Application
1.3.1 Global Rofecoxib Market Value by Application: (2024-2030)
1.3.2 Osteoarthritis
1.3.3 Rheumatoid Arthritis
1.3.4 Juvenile Rheumatoid Arthritis
1.3.5 Acute Pain Conditions
1.3.6 Migraine
1.3.7 Dysmenorrhea
1.4 Global Rofecoxib Market Size Estimates and Forecasts
1.4.1 Global Rofecoxib Revenue 2019-2030
1.4.2 Global Rofecoxib Sales 2019-2030
1.4.3 Global Rofecoxib Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Rofecoxib Market Competition by Manufacturers
2.1 Global Rofecoxib Sales Market Share by Manufacturers (2019-2024)
2.2 Global Rofecoxib Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Rofecoxib Average Price by Manufacturers (2019-2024)
2.4 Global Rofecoxib Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rofecoxib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rofecoxib, Product Type & Application
2.7 Rofecoxib Market Competitive Situation and Trends
2.7.1 Rofecoxib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rofecoxib Players Market Share by Revenue
2.7.3 Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rofecoxib Retrospective Market Scenario by Region
3.1 Global Rofecoxib Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Rofecoxib Global Rofecoxib Sales by Region: 2019-2030
3.2.1 Global Rofecoxib Sales by Region: 2019-2024
3.2.2 Global Rofecoxib Sales by Region: 2025-2030
3.3 Global Rofecoxib Global Rofecoxib Revenue by Region: 2019-2030
3.3.1 Global Rofecoxib Revenue by Region: 2019-2024
3.3.2 Global Rofecoxib Revenue by Region: 2025-2030
3.4 North America Rofecoxib Market Facts & Figures by Country
3.4.1 North America Rofecoxib Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Rofecoxib Sales by Country (2019-2030)
3.4.3 North America Rofecoxib Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rofecoxib Market Facts & Figures by Country
3.5.1 Europe Rofecoxib Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Rofecoxib Sales by Country (2019-2030)
3.5.3 Europe Rofecoxib Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rofecoxib Market Facts & Figures by Country
3.6.1 Asia Pacific Rofecoxib Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Rofecoxib Sales by Country (2019-2030)
3.6.3 Asia Pacific Rofecoxib Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rofecoxib Market Facts & Figures by Country
3.7.1 Latin America Rofecoxib Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Rofecoxib Sales by Country (2019-2030)
3.7.3 Latin America Rofecoxib Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rofecoxib Market Facts & Figures by Country
3.8.1 Middle East and Africa Rofecoxib Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Rofecoxib Sales by Country (2019-2030)
3.8.3 Middle East and Africa Rofecoxib Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Rofecoxib Sales by Type (2019-2030)
4.1.1 Global Rofecoxib Sales by Type (2019-2024)
4.1.2 Global Rofecoxib Sales by Type (2025-2030)
4.1.3 Global Rofecoxib Sales Market Share by Type (2019-2030)
4.2 Global Rofecoxib Revenue by Type (2019-2030)
4.2.1 Global Rofecoxib Revenue by Type (2019-2024)
4.2.2 Global Rofecoxib Revenue by Type (2025-2030)
4.2.3 Global Rofecoxib Revenue Market Share by Type (2019-2030)
4.3 Global Rofecoxib Price by Type (2019-2030)
5 Segment by Application
5.1 Global Rofecoxib Sales by Application (2019-2030)
5.1.1 Global Rofecoxib Sales by Application (2019-2024)
5.1.2 Global Rofecoxib Sales by Application (2025-2030)
5.1.3 Global Rofecoxib Sales Market Share by Application (2019-2030)
5.2 Global Rofecoxib Revenue by Application (2019-2030)
5.2.1 Global Rofecoxib Revenue by Application (2019-2024)
5.2.2 Global Rofecoxib Revenue by Application (2025-2030)
5.2.3 Global Rofecoxib Revenue Market Share by Application (2019-2030)
5.3 Global Rofecoxib Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Rofecoxib Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Rofecoxib Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Chengdu Meinkai Chemical Co. LTD
6.2.1 Chengdu Meinkai Chemical Co. LTD Corporation Information
6.2.2 Chengdu Meinkai Chemical Co. LTD Description and Business Overview
6.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Portfolio
6.2.5 Chengdu Meinkai Chemical Co. LTD Recent Developments/Updates
6.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
6.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
6.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Description and Business Overview
6.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Portfolio
6.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments/Updates
6.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
6.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
6.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description and Business Overview
6.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Portfolio
6.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Rofecoxib Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Rofecoxib Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Tremeau
6.6.1 Tremeau Corporation Information
6.6.2 Tremeau Description and Business Overview
6.6.3 Tremeau Rofecoxib Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Tremeau Rofecoxib Product Portfolio
6.6.5 Tremeau Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rofecoxib Industry Chain Analysis
7.2 Rofecoxib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rofecoxib Production Mode & Process
7.4 Rofecoxib Sales and Marketing
7.4.1 Rofecoxib Sales Channels
7.4.2 Rofecoxib Distributors
7.5 Rofecoxib Customers
8 Rofecoxib Market Dynamics
8.1 Rofecoxib Industry Trends
8.2 Rofecoxib Market Drivers
8.3 Rofecoxib Market Challenges
8.4 Rofecoxib Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Rofecoxib Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Rofecoxib Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Rofecoxib Market Competitive Situation by Manufacturers in 2023
Table 4. Global Rofecoxib Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Rofecoxib Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Rofecoxib Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Rofecoxib Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Rofecoxib Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Rofecoxib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Rofecoxib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rofecoxib, Product Type & Application
Table 12. Global Key Manufacturers of Rofecoxib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rofecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rofecoxib as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rofecoxib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Rofecoxib Sales by Region (2019-2024) & (K Units)
Table 18. Global Rofecoxib Sales Market Share by Region (2019-2024)
Table 19. Global Rofecoxib Sales by Region (2025-2030) & (K Units)
Table 20. Global Rofecoxib Sales Market Share by Region (2025-2030)
Table 21. Global Rofecoxib Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Rofecoxib Revenue Market Share by Region (2019-2024)
Table 23. Global Rofecoxib Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Rofecoxib Revenue Market Share by Region (2025-2030)
Table 25. North America Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Rofecoxib Sales by Country (2019-2024) & (K Units)
Table 27. North America Rofecoxib Sales by Country (2025-2030) & (K Units)
Table 28. North America Rofecoxib Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Rofecoxib Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Rofecoxib Sales by Country (2019-2024) & (K Units)
Table 32. Europe Rofecoxib Sales by Country (2025-2030) & (K Units)
Table 33. Europe Rofecoxib Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Rofecoxib Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Rofecoxib Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Rofecoxib Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Rofecoxib Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Rofecoxib Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Rofecoxib Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Rofecoxib Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Rofecoxib Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Rofecoxib Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Rofecoxib Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Rofecoxib Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Rofecoxib Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Rofecoxib Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Rofecoxib Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Rofecoxib Sales (K Units) by Type (2019-2024)
Table 51. Global Rofecoxib Sales (K Units) by Type (2025-2030)
Table 52. Global Rofecoxib Sales Market Share by Type (2019-2024)
Table 53. Global Rofecoxib Sales Market Share by Type (2025-2030)
Table 54. Global Rofecoxib Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Rofecoxib Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Rofecoxib Revenue Market Share by Type (2019-2024)
Table 57. Global Rofecoxib Revenue Market Share by Type (2025-2030)
Table 58. Global Rofecoxib Price (USD/Unit) by Type (2019-2024)
Table 59. Global Rofecoxib Price (USD/Unit) by Type (2025-2030)
Table 60. Global Rofecoxib Sales (K Units) by Application (2019-2024)
Table 61. Global Rofecoxib Sales (K Units) by Application (2025-2030)
Table 62. Global Rofecoxib Sales Market Share by Application (2019-2024)
Table 63. Global Rofecoxib Sales Market Share by Application (2025-2030)
Table 64. Global Rofecoxib Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Rofecoxib Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Rofecoxib Revenue Market Share by Application (2019-2024)
Table 67. Global Rofecoxib Revenue Market Share by Application (2025-2030)
Table 68. Global Rofecoxib Price (USD/Unit) by Application (2019-2024)
Table 69. Global Rofecoxib Price (USD/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Merck Rofecoxib Product
Table 74. Merck Recent Developments/Updates
Table 75. Chengdu Meinkai Chemical Co. LTD Corporation Information
Table 76. Chengdu Meinkai Chemical Co. LTD Description and Business Overview
Table 77. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product
Table 79. Chengdu Meinkai Chemical Co. LTD Recent Developments/Updates
Table 80. Wuhan Xinxin Jiali Biotechnology Co. LTD Corporation Information
Table 81. Wuhan Xinxin Jiali Biotechnology Co. LTD Description and Business Overview
Table 82. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product
Table 84. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments/Updates
Table 85. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Corporation Information
Table 86. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Description and Business Overview
Table 87. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product
Table 89. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Rofecoxib Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Tremeau Corporation Information
Table 96. Tremeau Description and Business Overview
Table 97. Tremeau Rofecoxib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Tremeau Rofecoxib Product
Table 99. Tremeau Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Rofecoxib Distributors List
Table 103. Rofecoxib Customers List
Table 104. Rofecoxib Market Trends
Table 105. Rofecoxib Market Drivers
Table 106. Rofecoxib Market Challenges
Table 107. Rofecoxib Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rofecoxib
Figure 2. Global Rofecoxib Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Rofecoxib Market Share by Type in 2023 & 2030
Figure 4. Oral Suspension. Product Picture
Figure 5. Tablet-Form Product Picture
Figure 6. Global Rofecoxib Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Rofecoxib Market Share by Application in 2023 & 2030
Figure 8. Osteoarthritis
Figure 9. Rheumatoid Arthritis
Figure 10. Juvenile Rheumatoid Arthritis
Figure 11. Acute Pain Conditions
Figure 12. Migraine
Figure 13. Dysmenorrhea
Figure 14. Global Rofecoxib Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Rofecoxib Market Size (2019-2030) & (US$ Million)
Figure 16. Global Rofecoxib Sales (2019-2030) & (K Units)
Figure 17. Global Rofecoxib Average Price (USD/Unit) & (2019-2030)
Figure 18. Rofecoxib Report Years Considered
Figure 19. Rofecoxib Sales Share by Manufacturers in 2023
Figure 20. Global Rofecoxib Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Rofecoxib Players: Market Share by Revenue in 2023
Figure 22. Rofecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Rofecoxib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Rofecoxib Sales Market Share by Country (2019-2030)
Figure 25. North America Rofecoxib Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Rofecoxib Sales Market Share by Country (2019-2030)
Figure 29. Europe Rofecoxib Revenue Market Share by Country (2019-2030)
Figure 30. Germany Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Rofecoxib Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Rofecoxib Revenue Market Share by Region (2019-2030)
Figure 37. China Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Rofecoxib Sales Market Share by Country (2019-2030)
Figure 48. Latin America Rofecoxib Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Rofecoxib Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Rofecoxib Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. U.A.E Rofecoxib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Rofecoxib by Type (2019-2030)
Figure 58. Global Revenue Market Share of Rofecoxib by Type (2019-2030)
Figure 59. Global Rofecoxib Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Rofecoxib by Application (2019-2030)
Figure 61. Global Revenue Market Share of Rofecoxib by Application (2019-2030)
Figure 62. Global Rofecoxib Price (USD/Unit) by Application (2019-2030)
Figure 63. Rofecoxib Value Chain
Figure 64. Rofecoxib Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
